GUNA-MATRIX

Active substance: ASCORBIC ACID, SUS SCROFA CONJUNCTIVA, PRASTERONE, MALIC ACID, FUCUS VESICULOSUS, HISTIDINE MONOHYDROCHLORIDE, HYALURONIDASE, HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED), LACTIC ACID, DL-, SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE, NADIDE, SODIUM DIETHYL OXALACETATE, SODIUM PYRUVATE, SODIUM SULFATE, PHENYLALANINE, PROLACTIN, RANCID BEEF, THUJA OCCIDENTALIS LEAFY TWIG, DODECAHYDROXYCYCLOHEXANE DIHYDRATE, TYROSINE

SOLUTION/ DROPS · ASCORBIC ACID 4 [hp_X]/30mL, SUS SCROFA CONJUNCTIVA 6 [hp_X]/30mL, PRASTERONE 6 [hp_X]/30mL, MALIC ACID 6 [hp_X]/30mL, FUCUS VESICULOSUS 4 [hp_X]/30mL, HISTIDINE MONOHYDROCHLORIDE 4 [hp_X]/30mL, HYALURONIDASE 6 [hp_X]/30mL, HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) 4 [hp_C]/30mL, LACTIC ACID, DL- 4 [hp_X]/30mL, SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE 6 [hp_X]/30mL, NADIDE 6 [hp_X]/30mL, SODIUM DIETHYL OXALACETATE 6 [hp_X]/30mL, SODIUM PYRUVATE 6 [hp_X]/30mL, SODIUM SULFATE 12 [hp_X]/30mL, PHENYLALANINE 4 [hp_X]/30mL, PROLACTIN 6 [hp_X]/30mL, RANCID BEEF 12 [hp_X]/30mL, THUJA OCCIDENTALIS LEAFY TWIG 12 [hp_X]/30mL, DODECAHYDROXYCYCLOHEXANE DIHYDRATE 6 [hp_X]/30mL, TYROSINE 4 [hp_X]/30mL

United StatesActive

Marketing holder: Guna spa

Verified 2026-10-09 · openFDA NDC

Source: openFDA NDC

Composition

ASCORBIC ACID · 4 [hp_X]/30mL
SUS SCROFA CONJUNCTIVA · 6 [hp_X]/30mL
PRASTERONE · 6 [hp_X]/30mL
MALIC ACID · 6 [hp_X]/30mL
FUCUS VESICULOSUS · 4 [hp_X]/30mL
HISTIDINE MONOHYDROCHLORIDE · 4 [hp_X]/30mL
HYALURONIDASE · 6 [hp_X]/30mL
HUMAN INTERLEUKIN-6 (NONGLYCOSYLATED) · 4 [hp_C]/30mL
LACTIC ACID, DL- · 4 [hp_X]/30mL
SUS SCROFA SMALL INTESTINE MUCOSA LYMPH FOLLICLE · 6 [hp_X]/30mL
NADIDE · 6 [hp_X]/30mL
SODIUM DIETHYL OXALACETATE · 6 [hp_X]/30mL
SODIUM PYRUVATE · 6 [hp_X]/30mL
SODIUM SULFATE · 12 [hp_X]/30mL
PHENYLALANINE · 4 [hp_X]/30mL
PROLACTIN · 6 [hp_X]/30mL
RANCID BEEF · 12 [hp_X]/30mL
THUJA OCCIDENTALIS LEAFY TWIG · 12 [hp_X]/30mL
DODECAHYDROXYCYCLOHEXANE DIHYDRATE · 6 [hp_X]/30mL
TYROSINE · 4 [hp_X]/30mL

Registration

Registration number: 17089-416
Registration status: Active
Dispensing: Over the counter
Route: ORAL

Sources

product · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
registration_status · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.0 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.1 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.2 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.3 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.4 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.5 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.6 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.7 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.8 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.9 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.10 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.11 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.12 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.13 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.14 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.15 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.16 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.17 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.18 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source
ingredients.19 · openFDA NDC · 17089-416 · Verified 2026-10-09 · open in source